NDC 35781-0301-0 - Lidodose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 35781-0301
- Requested NDC
- 35781-0301-0
- Package NDCs from labels
- 35781-0301-0, 35781-0301-5, 35781-0301-1
- Manufacturer
- Gensco Laboratories, LLC
- Effective date
- 2022-10-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidodose - Gensco Laboratories, LLC | Gensco Laboratories, LLC | 2022-10-04 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 35781-0301-1 | 2023-07-28 | LidoDose Topical Anesthetic |
| 35781-0301-5 | 2023-07-28 | LidoDose Topical Anesthetic |
| 35781-0301-1 | 2022-10-05 | LidoDose Topical Anesthetic |
| 35781-0301-5 | 2022-10-05 | LidoDose Topical Anesthetic |
| 35781-0301-1 | 2022-07-29 | LidoDose Topical Anesthetic |
| 35781-0301-5 | 2022-07-29 | LidoDose Topical Anesthetic |
| 35781-0301-1 | 2020-09-14 | LidoDose Topical Anesthetic |
| 35781-0301-5 | 2020-09-14 | LidoDose Topical Anesthetic |
| 35781-0301-1 | 2020-07-22 | LidoDose Topical Anesthetic |
| 35781-0301-5 | 2020-07-22 | LidoDose Topical Anesthetic |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 35781-0301-0 | Lidodose | 1 mL in 1 POUCH | GEL | 1 | 7 | |
| 35781-0301-1 | Lidodose | 100 in 1 BOX | GEL | 100 | 7 | |
| 35781-0301-5 | Lidodose | 25 in 1 BOX | GEL | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 35781-0301 | LIDODOSE (LIDOCAINE HYDROCHLORIDE) GEL [GENSCO LABORATORIES, LLC] | 7 | Legacy NDC, 3 package rows | 20221006_0b3e8433-4f93-4f01-9df0-020fb6922bce.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 35781-0301-0 | ML - Milliliter | 35781-0301 | ffc9fee0-57af-4fd1-bdfe-2944d888a283 | 1 | 2018-08-13 |
| 35781-0301-1 | ML - Milliliter | 35781-0301 | ee48ab42-3c99-400e-ad2a-4cf6a13cb5f8 | 1 | 2019-04-11 |
| 35781-0301-5 | ML - Milliliter | 35781-0301 | cf10e88e-9a11-4224-9050-ee0310a8b309 | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | STERILE WATER | Chartwell RX, LLC | 3681eeaa-807a-47ca-9fbc-61c2b682800a | 2024-02-01 | 059QF0KO0R | |
| Sterile Water | WATER | A-S Medication Solutions | dba87371-31d2-47c2-ab83-89aabce4b184 | 2024-01-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Mirakel Pain Relief Roll-On | LIDOCAINE HCL | Sanvio, Inc. | 102f3618-13ad-37e3-e063-6294a90a8086 | 2024-01-30 | Warnings | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 8c63be55-5de4-7f72-e053-2995a90a102e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999dd95d-87fe-12c0-e053-2995a90aa9f7 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4bf5905-add7-1cb0-e053-2995a90a7334 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4c0df51-cc37-323d-e053-2995a90a154a | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 7a664a34-19fd-4a7b-ab4d-11299b32999e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | fd6343a9-15a6-4894-b51f-122e4d6dbe79 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Seton Pharmaceuticals | 1c0abe84-5404-404e-b882-e910e4d43ffb | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 951862db-3a73-4d25-9d5b-e4111833f43b | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 6aa284d6-0212-4fb5-809d-c721aa6fe2ba | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Cetaphil Baby Healing | PETROLATUM | Galderma Laboratories, L.P. | 5140754e-5db0-470f-adfd-de02b184880b | 2024-01-29 | Warnings | 4T6H12BN9U |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c4c16714-6b1f-857e-e053-2a95a90a74e4 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8bc96bc-7876-4906-e053-2a95a90ae6ba | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e39435a3-1f69-78c5-e053-2995a90a7fc3 | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| 0.5% LIDOCAINE HCl | 0.5% LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e52fe254-8872-35ce-e053-2a95a90a339e | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.